VR Logo

Ipca Laboratories Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

38 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of allopathic pharmaceutical preparations

Incorporated: 1949

Chairman: Premchand Godha

Managing Director: Premchand Godha

Group: Ipca Laboratories

Listing: NSE: IPCALAB, BSE: 524494

Headquarters: Mumbai, Maharashtra

Website: www.ipcalabs.com

Key Facts

Market cap: R 20,165.16 Cr

Revenue (TTM): R 4,454.56 Cr

Earnings (TTM): R 622.98 Cr

Cash: R 372.68 Cr

Total Debt: R 464.95 Cr

Promoters' ownership: 46.07%

Liquidity: High

52 Week range: R 844.65 - 1,825.00

Face value: R2.00

Shares outstanding: 12,63,52,109

10 Years Aggregate:

  • CFO: 3,962.74 Cr
  • EBITDA: 4,642.41 Cr
  • Net Profit: 2,790.41 Cr

Stock Performance

Time Period Ipca Laboratories S&P BSE Healthcare S&P BSE Mid Cap
YTD40.3015.56-24.71
1 month2.092.59-2.57
3 months9.596.76-28.19
1 Year72.4416.76-23.19
3 Years45.242.02-7.98
5 Years19.57-1.901.19
10 Years20.5511.375.35
As on 22-May-2020
Year Ipca Laboratories S&P BSE Mid Cap S&P BSE Healthcare
201939.19-3.05-3.55
201833.85-13.31-5.89
201712.2448.130.49
2016-28.197.97-12.88
20152.957.4315.06
20141.3254.6947.43
201338.06-5.7322.55